Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-25-107728
Filing Date
2025-11-07
Accepted
2025-11-07 17:30:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 11617
  Complete submission text file 0001213900-25-107728.txt   13524
Mailing Address 677 N. WASHINGTON BLVD SARASOTA FL 34236
Business Address 677 N. WASHINGTON BLVD SARASOTA FL 34236 (718) 400-9031
Silo Pharma, Inc. (Subject) CIK: 0001514183 (see all company filings)

EIN.: 462137136 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-87110 | Film No.: 251463743
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 245 PALM TRAIL DELRAY BEACH FL 33483
Business Address 245 PALM TRAIL DELRAY BEACH FL 33483 8475629030
INTRACOASTAL CAPITAL, LLC (Filed by) CIK: 0001646799 (see all company filings)

EIN.: 320460881 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A